Clinical trials in Anniston, AL

12 recruiting studies have a site in or near Anniston, AL, Alabama.

Top conditions here

All conditions

Showing 12 of 12 studies

RecruitingPhase 1NCT06916806

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Sponsor: AstraZeneca

Anniston, AL · Birmingham, AL · +5 more sites

RecruitingPhase 1NCT07607964

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)

Sponsor: AbbVie

Anniston, AL · +10 more sites

RecruitingPhase 3NCT07064473

EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease

Sponsor: Boehringer Ingelheim

Anniston, AL · Fairhope, AL · Guntersville, AL · +205 more sites

RecruitingPhase 3NCT06133972

Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).

Sponsor: Novartis Pharmaceuticals

Anniston, AL · +24 more sites

RecruitingPhase 3NCT07351045

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Sponsor: Hoffmann-La Roche

Anniston, AL · Birmingham, AL · +41 more sites

RecruitingPhase 3NCT07794579

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Sponsor: Eli Lilly and Company

Anniston, AL · Birmingham, AL · Pelham, AL · +77 more sites

RecruitingPhase 3NCT07843472

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Established Cardiovascular Disease

Sponsor: Hoffmann-La Roche

Anniston, AL · +2 more sites

RecruitingPhase 3NCT07843498

A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

Sponsor: Hoffmann-La Roche

Anniston, AL · +2 more sites

RecruitingPhase 3NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Sponsor: Amgen

Anniston, AL · Daphne, AL · Mobile, AL · +68 more sites

RecruitingPhase 3NCT07430306

A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus

Sponsor: AstraZeneca

Anniston, AL · Birmingham, AL · +29 more sites

RecruitingPhase 1NCT07258849

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

Sponsor: Eli Lilly and Company

Anniston, AL · +8 more sites

RecruitingNot applicableNCT05003310

ConsideRAte Study - Splenic Stimulation for RA

Sponsor: Galvani Bioelectronics

Anniston, AL · +11 more sites

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.